Correction: Méroc et al. Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine. 2023, , 1816.
作者信息
Méroc Estelle, Fletcher Mark A, Hanquet Germaine, Slack Mary P E, Baay Marc, Hayford Kyla, Gessner Bradford D, Grant Lindsay R
机构信息
P95 Epidemiology & Pharmacovigilance, Koning Leopold III-laan 1, 3001 Leuven, Belgium.
Emerging Markets Medical Affairs, Vaccines, Pfizer, 23-25 Av. du Dr Lannelongue, 75014 Paris, France.
出版信息
Microorganisms. 2025 Mar 31;13(4):793. doi: 10.3390/microorganisms13040793.
Abstract
In the original publication [...].
摘要
相似文献
1
Correction: Méroc et al. Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine. 2023, , 1816.
Microorganisms. 2025 Mar 31;13(4):793. doi: 10.3390/microorganisms13040793.
2
20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.20价肺炎球菌结合疫苗：成人使用情况综述
Drugs. 2022 Jun;82(9):989-999. doi: 10.1007/s40265-022-01733-z. Epub 2022 Jul 6.
3
Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine.20价肺炎球菌结合疫苗所覆盖的额外血清型引起的肺炎球菌疾病流行病学特征的系统文献综述
Microorganisms. 2023 Jul 15;11(7):1816. doi: 10.3390/microorganisms11071816.
4
Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study.在英格兰，1 + 1 婴儿免疫计划中用 15 价或 20 价肺炎球菌结合疫苗替代 13 价肺炎球菌结合疫苗的潜在影响：一项建模研究。
Lancet Public Health. 2024 Sep;9(9):e654-e663. doi: 10.1016/S2468-2667(24)00161-0. Epub 2024 Aug 14.
5
Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).预防婴幼儿肺炎球菌病-使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗-免疫实践咨询委员会（ACIP）的建议。
MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18.
6
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children.儿童高价肺炎球菌结合疫苗预防侵袭性肺炎球菌病失败和突破性疾病的系统评价
Expert Rev Vaccines. 2022 Feb;21(2):201-214. doi: 10.1080/14760584.2022.2012455. Epub 2022 Feb 3.
7
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.13 价肺炎球菌结合疫苗在英国和威尔士引入 4 年后对侵袭性肺炎球菌病的影响：一项观察性队列研究。
Lancet Infect Dis. 2015 May;15(5):535-43. doi: 10.1016/S1473-3099(15)70044-7. Epub 2015 Mar 20.
8
Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States.在美国，13 价和新型更高价肺炎球菌结合疫苗涵盖血清型导致的肺炎球菌病负担。
Vaccine. 2022 Aug 5;40(33):4700-4708. doi: 10.1016/j.vaccine.2022.06.024. Epub 2022 Jun 24.
9
The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value.20价肺炎球菌结合疫苗（PCV20）：预期附加值。
Acta Clin Belg. 2023 Feb;78(1):78-86. doi: 10.1080/17843286.2022.2039865. Epub 2022 Feb 16.
10
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.13 价肺炎球菌结合疫苗替代 7 价肺炎球菌结合疫苗对挪威侵袭性肺炎球菌病流行病学的影响。
Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.
本文引用的文献
1
Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine.20价肺炎球菌结合疫苗所覆盖的额外血清型引起的肺炎球菌疾病流行病学特征的系统文献综述
Microorganisms. 2023 Jul 15;11(7):1816. doi: 10.3390/microorganisms11071816.
Zotero 插件